Abstract
Parafibromin is a nuclear protein with a tumour suppressor role in the development of non-hereditary and hereditary parathyroid carcinomas, and the hyperparathyroidism-jaw tumour (HPT-JT) syndrome, which is associated with renal and uterine tumours. Nuclear localization signal(s), (NLS(s)), of the 61 kDa parafibromin remain to be defined. Utilization of computer-prediction programmes, identified five NLSs (three bipartite (BP) and two monopartite (MP)). To investigate their functionality, wild-type (WT) and mutant parafibromin constructs tagged with enhanced green fluorescent protein or cMyc were transiently expressed in COS-7 cells, or human embryonic kidney 293 (HEK293) cells, and their subcellular locations determined by confocal fluorescence microscopy. Western blot analyses of nuclear and cytoplasmic fractions from the transfected cells were also performed. WT parafibromin localized to the nucleus and deletions or mutations of the three predicted BP and one of the predicted MP NLSs did not affect this localization. In contrast, deletions or mutations of a MP NLS, at residues 136–139, resulted in loss of nuclear localization. Furthermore, the critical basic residues, KKXR, of this MP NLS were found to be evolutionarily conserved, and over 60% of all parafibromin mutations lead to a loss of this NLS. Thus, an important functional domain of parafibromin, consisting of an evolutionarily conserved MP NLS, has been identified.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
Accessions
GenBank/EMBL/DDBJ
References
Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G . (1993). Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 7: 812–821.
Bradley KJ, Cavaco BM, Bowl MR, Harding B, Cranston T, Fratter C et al. (2006). Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours. Clin Endocrinol (Oxford) 64: 299–306.
Bradley KJ, Hobbs MR, Buley ID, Carpten JD, Cavaco BM, Fares JE et al. (2005). Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome. J Intern Med 257: 18–26.
Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J et al. (2002). HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 32: 676–680.
Cavaco BM, Barros L, Pannett AA, Ruas L, Carvalheiro M, Ruas MM et al. (2001). The hyperparathyroidism-jaw tumour syndrome in a Portuguese kindred. QJ Med 94: 213–222.
Cokol M, Nair R, Rost B . (2000). Finding nuclear localization signals. EMBO Rep 1: 411–415.
Fabbro M, Henderson BR . (2003). Regulation of tumor suppressors by nuclear-cytoplasmic shuttling. Exp Cell Res 282: 59–69.
Fontes MR, Teh T, Jans D, Brinkworth RI, Kobe B . (2003). Structural basis for the specificity of bipartite nuclear localization sequence binding by importin-alpha. J Biol Chem 278: 27981–27987.
Guru SC, Goldsmith PK, Burns AL, Marx SJ, Spiegel AM, Collins FS et al. (1998). Menin, the product of the MEN1 gene, is a nuclear protein. Proc Natl Acad Sci USA 95: 1630–1634.
Hahn MA, Marsh DJ . (2005). Identification of a functional bipartite nuclear localization signal in the tumor suppressor parafibromin. Oncogene 24: 6241–6248.
Haven CJ, Wong FK, van Dam EW, van der Juijt R, van Asperen C, Jansen J et al. (2000). A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 85: 1449–1454.
Hodel MR, Corbett AH, Hodel AE . (2001). Dissection of a nuclear localization signal. J Biol Chem 276: 1317–1325.
Howell VM, Haven CJ, Kahnoski K, Khoo SK, Petillo D, Chen J et al. (2003). HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet 40: 657–663.
Hunter T, Pines J . (1994). Cyclins and cancer. II: cyclin D and CDK inhibitors come of age. Cell 79: 573–582.
Kennedy AM, Inada M, Krane SM, Christie PT, Harding B, Lopez-Otin C et al. (2005). MMP13 mutation causes spondyloepimetaphyseal dysplasia, Missouri type (SEMD(MO). J Clin Invest 115: 2832–2842.
Knudson Jr AG . (1971). Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820–823.
Krauer K, Buck M, Flanagan J, Belzer D, Sculley T . (2004). Identification of the nuclear localization signals within the Epstein–Barr virus EBNA-6 protein. J Gen Virol 85 (Part 1): 165–172.
Nakielny S, Dreyfuss G . (1999). Transport of proteins and RNAs in and out of the nucleus. Cell 99: 677–690.
Nesbit MA, Bowl MR, Harding B, Ali A, Ayala A, Crowe C et al. (2004). Characterization of GATA3 mutations in the hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome. J Biol Chem 279: 22624–22634.
Quadrini KJ, Bieker JJ . (2002). Kruppel-like zinc fingers bind to nuclear import proteins and are required for efficient nuclear localization of erythroid Kruppel-like factor. J Biol Chem 277: 32243–32252.
Rozenblatt-Rosen O, Hughes CM, Nannepaga SJ, Shanmugam KS, Copeland TD, Guszczynski T et al. (2005). The parafibromin tumor suppressor protein is part of a human Paf1 complex. Mol Cell Biol 25: 612–620.
Shattuck TM, Valimaki S, Obara T, Gaz RD, Clark OH, Shoback D et al. (2003). Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349: 1722–1729.
Szabo J, Heath B, Hill VM, Jackson CE, Zarbo RJ, Mallette LE et al. (1995). Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. Am J Hum Genet 56: 944–950.
Tan MH, Morrison C, Wang P, Yang X, Haven CJ, Zhang C et al. (2004). Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clin Cancer Res 10: 6629–6637.
Teh BT, Farnebo F, Kristoffersson U, Sundelin B, Cardinal J, Axelson R et al. (1996). Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas. J Clin Endocrinol Metab 81: 4204–4211.
Thakker RV, Juppner H . (2006). Genetic disorders of calcium homeostasis caused by abnormal regulation of parathyroid hormone secretion or responsiveness. In: Degroot LJ, Jameson JL (eds). Endocrinology, 5th edn, vol. 2. Elsevier Saunders: Philadelphia, pp. 1511–1531.
Vandenbroucke I, Van Oostveldt P, Coene E, De Paepe A, Messiaen L . (2004). Neurofibromin is actively transported to the nucleus. FEBS Lett 560: 98–102.
Woodard GE, Lin L, Zhang JH, Agarwal SK, Marx SJ, Simonds WF . (2004). Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression. Oncogene 24: 1272–1276.
Yart A, Gstaiger M, Wirbelauer C, Pecnik M, Anastasiou D, Hess D et al. (2005). The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II. Mol Cell Biol 25: 5052–5060.
Zacksenhaus E, Bremner R, Phillips RA, Gallie BL . (1993). A bipartite nuclear localization signal in the retinoblastoma gene product and its importance for biological activity. Mol Cell Biol 13: 4588–4599.
Acknowledgements
We are grateful for support to the Medical Research Council (KJB, MRB, ALP, AMK and RVT), EuReGene (NYL and RVT), the Wellcome Trust (BNA, CJP, NYL and RVT) and the National Kidney Research Fund (SEW and RVT). KJB is an MRC (UK) Clinical Training Fellow.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bradley, K., Bowl, M., Williams, S. et al. Parafibromin is a nuclear protein with a functional monopartite nuclear localization signal. Oncogene 26, 1213–1221 (2007). https://doi.org/10.1038/sj.onc.1209893
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1209893
Keywords
This article is cited by
-
Oxoglutarate dehydrogenase-like inhibits the progression of hepatocellular carcinoma by inducing DNA damage through non-canonical function
Cell Death & Differentiation (2023)
-
Physical model of the nuclear membrane permeability mechanism
Biophysical Reviews (2023)
-
Overview of the 2022 WHO Classification of Parathyroid Tumors
Endocrine Pathology (2022)
-
Types of nuclear localization signals and mechanisms of protein import into the nucleus
Cell Communication and Signaling (2021)
-
Genomics and Epigenomics in Parathyroid Neoplasia: from Bench to Surgical Pathology Practice
Endocrine Pathology (2021)